Loading today’s stories

Today

AI-assisted reporting, grounded in a per-article claim ledger. Perspective Coverage and Reality Strip separate source viewpoints from evidence, adoption, hype, incentives, and confidence.

Today

Front Page
Today’s Briefing
Newsletters
Trending
For You
Discover
My Stack
Saved
Off Radar
Search

Sections

Security
Build
Invest
Product
Leadership
Science

Company

About
Mission
How this is made
Evidence Index
The desks
The sources we read
Corrections
Press and brand
The daily edition

Trending now

Agentic AI Security
AI-assisted vulnerability research
LLM Evaluation Methodology
AI-Generated Code Security
On-Chain Market Structure
AI IPO valuation
Total addressable market claims
Post-Quantum Cryptography
AI Agent Evaluation
Generative materials discovery

How this is made

Today For You My Stack Off Radar Search

AS01 — other — Clarity Today

other

AS01

Immune-stimulating adjuvant present in Shingrix but not Zostavax, hypothesised to reprogramme monocytes and reduce inflammatory cytokines.

Known aliases

AS01 adjuvant

Relationships

No evidence-backed relationships are recorded.

Current clusters

science2 distinct publishers

Oxford's Zostavax-to-Shingrix switch closes the healthy-vaccinee loophole, and opens another

A natural experiment at the October 2017 vaccine changeover gives the cardiovascular claim a cleaner comparison group. It also means nobody has yet measured Shingrix against no vaccine.

Publishers:newscientist.com · statnews.com

Reality

Evidence63
Adoption58
Hype gap+20
Incentives42

Confidence74